Stock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill

Stock Track01-09

Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.

The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.

Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

glr
01-10
glr
what is the expected price growth of this deal ?

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137467830?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-09 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137467830","market":"hk","top_or_hot":-1,"title":"Stock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill","media":"Stock Track","content":"<p>Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.</p><p>The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.</p><p>Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-09 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.</p><p>The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.</p><p>Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"","article_id":"1137467830","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137467830","pubTimestamp":1767969744,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德"},"translate_title":"个股追踪|亚马逊药房推出Wegovy减肥药，诺和诺德盘中大涨5.01%","themeId":"664644e041d7d1a3c24b84c8bab49d56","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1},"content_text":"Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":520071698497592,"gmtCreate":1768005872916,"gmtModify":1768007232982,"author":{"id":"3582612504286910","authorId":"3582612504286910","name":"glr","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3582612504286910","idStr":"3582612504286910"},"htmlText":"what is the expected price growth of this deal ?","listText":"what is the expected price growth of this deal ?","text":"what is the expected price growth of this deal ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/520071698497592","repostId":1137467830,"repostType":2,"repost":{"id":"1137467830","kind":"news","weMediaInfo":{"introduction":"Track stock‘s movements and relevant news","home_visible":1,"media_name":"Stock Track","id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1767969744,"share":"https://ttm.financial/m/news/1137467830?lang=en_US&edition=fundamental","pubTime":"2026-01-09 22:42","market":"hk","language":"en","title":"Stock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1137467830","media":"Stock Track","summary":"Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy,...","content":"<p>Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.</p><p>The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.</p><p>Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.</p>","source":"ai_movement_en","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Novo-Nordisk Soars 5.01% Intraday as Amazon Pharmacy Launches Wegovy Weight-Loss Pill\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-09 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.</p><p>The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.</p><p>Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVO":"诺和诺德"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137467830","content_text":"Novo-Nordisk A/S (NVO) shares surged 5.01% during Friday's intraday trading session following Amazon Pharmacy's announcement that it will now offer the company's oral weight-loss drug, Wegovy, through its platform.The move marks the first time the FDA-approved GLP-1 medication is available in pill form, with Amazon Pharmacy offering it at competitive prices: as low as $25 per month for insured customers and $149 for cash-pay options. The platform also provides nationwide home delivery, including same-day service in some areas, significantly expanding Wegovy's accessibility.Market analysts view this partnership as a strategic win for Novo-Nordisk, reinforcing its dominance in the weight-loss drug market and potentially disrupting traditional pharmacy distribution channels. The news has fueled investor optimism, driving the stock's sharp upward movement.","news_type":1,"symbols_score_info":{"NVO":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137467830","isCrawlerRequest":true}